|
|
Understanding role of circadian disruption in pathogenesis of MS |
| 1R01NS123532-01A1 |
|
NINDS |
2022 |
|
|
Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep Phenotyping |
| 1R01NS126227-01 |
|
NINDS |
2022 |
|
|
Exploring Akkermansia Genomic and Functional Diversity in Neurologic Diseases |
| 1R21NS126866-01 |
|
NINDS |
2022 |
|
|
Investigating how the microbiota modulates neuroinflammatory signaling and neurodegeneration in Parkinsons disease and dementia |
| 1R21NS130500-01 |
|
NINDS |
2022 |
|
|
KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target |
| 1R37NS125632-01 |
|
NINDS |
2022 |
|
|
α-Synuclein strain properties are associated with diagnosis of and progression to Parkinsons disease with dementia |
| 1RF1NS125592-01 |
|
NINDS |
2022 |
|
|
α-Synuclein strain properties are associated with diagnosis of and progression to Parkinsons disease with dementia |
| 1RF1NS125592-01 |
|
NINDS |
2022 |
|
|
Immune modulating therapies to treat complex regional pain syndrome |
| 1RF1NS130481-01 |
|
NINDS |
2022 |
|
|
Immune modulating therapies to treat complex regional pain syndrome |
| 1RF1NS130481-01 |
|
NINDS |
2022 |
|
|
Multi-Center Clinical Trial of Spinal Cord Stimulation to Restore Cough |
| 1UG3NS121560-01A1 |
|
NINDS |
2022 |